Although P2Y6 receptors play different roles in GC and pancreatic cancer, our findings suggest that the P2Y6 receptor-mediated novel downstream pathways might be potential targets for innovative GC prevention/therapy. This evidence concerns the gene P2RY6 and familial pancreatic carcinoma.